Noile-Immune Biotech Inc. had a revenue of 2.14M in the quarter ending Mar 31, 2025, with 7.10%. This bring the company's revenue in the last twelve months to 7.14M, Increased -5.87%. In the fiscal year ending Dec 31, 2024, Noile-Immune Biotech Inc. had annual revenue of 7.59M with -97.61% growth.